Henry A. Fernandez - 31 Mar 2023 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
Director
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Henry A. Fernandez
Issuer symbol
RPRX
Transactions as of
31 Mar 2023
Net transactions value
+$37,478
Form type
4
Filing time
31 Mar 2023, 16:40:31 UTC
Previous filing
10 Feb 2023
Next filing
26 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Award $37,478 +1,049 +3.7% $35.73 29,036 31 Mar 2023 Direct F1
holding RPRX Class A Ordinary Shares 58,200 31 Mar 2023 By Fernandez 2007 Children's Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.